CDK8-IN-11 is a potent and selective CDK8 inhibitor with an IC50 value of 46 nM. CDK8-IN-11 inhibits WNT/beta-catenin signaling pathway. CDK8-IN-11 can be used in the research of colon cancer[1].
Molecular Weight:
388.34
Purity:
98.20
CAS Number:
[2839338-28-0]
Formula:
C19H15F3N4O2
Target:
CDK,beta-catenin
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted